Deferasirox combination with eltrombopag shows anti-myelodysplastic syndrome effects by enhancing iron deprivation–related apoptosis
Lei Huang, Mengyue Tian, Zhaoyun Liu, Chunyan Liu, Rong Fu
DOI: 10.1136/jim-2021-002147 Published 11 April 2022
Lei Huang
Hematology, Tianjin Medical University General Hospital, Tianjin, China
Mengyue Tian
Hematology, Tianjin Medical University General Hospital, Tianjin, China
Zhaoyun Liu
Hematology, Tianjin Medical University General Hospital, Tianjin, China
Chunyan Liu
Hematology, Tianjin Medical University General Hospital, Tianjin, China
Rong Fu
Hematology, Tianjin Medical University General Hospital, Tianjin, China
Submit a Response to This Article
No eLetters have been published for this article.
Deferasirox combination with eltrombopag shows anti-myelodysplastic syndrome effects by enhancing iron deprivation–related apoptosis
Lei Huang, Mengyue Tian, Zhaoyun Liu, Chunyan Liu, Rong Fu
Journal of Investigative Medicine Apr 2022, 70 (4) 953-962; DOI: 10.1136/jim-2021-002147
Deferasirox combination with eltrombopag shows anti-myelodysplastic syndrome effects by enhancing iron deprivation–related apoptosis
Lei Huang, Mengyue Tian, Zhaoyun Liu, Chunyan Liu, Rong Fu
Journal of Investigative Medicine Apr 2022, 70 (4) 953-962; DOI: 10.1136/jim-2021-002147